Sulfasymazine
(Synonyms: 磺胺均三嗪) 目录号 : GC32304Sulfasymazine是一种磺酰胺类药物,表现出抗菌特性。
Cas No.:1984-94-7
Sample solution is provided at 25 µL, 10mM.
Sulfasymazine is a sulfonamide drug and displays antibacterial properties.
Sulfasymazine is a sulfonamide drug and displays antibacterial properties. On a dosage basis, Sulfasymazine is from 2 to 10 times more potent than sulfisoxazole; on a blood level basis, Sulfasymazine potency ranges from 0.3 to 1. In acute toxicity studies in mice, the sodium salt of Sulfasymazine is tolerated at 2000 mg/kg orally, and at 1000 mg/kg intraperitoneally[1].
[1]. Redin GS, et al. An evaluation of sulfasymazine in infections in mice. Chemotherapy. 1966;11(6):309-14.
Animal experiment: | Carworth Farms CF-1 mice, 4 to 6 weeks of age, weighing 19 to 22 g are used in this study. The mice are infected by intraperitoneal injection of the several bacteria strains. Sulfasymazine is administered either in the diet or in a single dose by gavage. With the drug-diet method, each group of 10 mice is permitted to feed at will from 1 day before infection to 6 days after infection from a common hopper containing Sulfasymazine uniformly mixed with ground Wayne Mouse Blox. The mice are kept under conditions of alternating 3 h periods of light and dark, in order to encourage eating at more or less regular intervals throughout each 24-h period. Drug intakes, as mg per kg of body weight per day, are determined by calculations based on the initial average weight of the mice, the total diet consumed during the treatment period, and the concentration of drug in the diet[1]. |
References: [1]. Redin GS, et al. An evaluation of sulfasymazine in infections in mice. Chemotherapy. 1966;11(6):309-14. |
Cas No. | 1984-94-7 | SDF | |
别名 | 磺胺均三嗪 | ||
Canonical SMILES | O=S(C1=CC=C(N)C=C1)(NC2=NC(CC)=NC(CC)=N2)=O | ||
分子式 | C13H17N5O2S | 分子量 | 307.37 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.2534 mL | 16.267 mL | 32.5341 mL |
5 mM | 0.6507 mL | 3.2534 mL | 6.5068 mL |
10 mM | 0.3253 mL | 1.6267 mL | 3.2534 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet